0001104659-23-105403.txt : 20230929
0001104659-23-105403.hdr.sgml : 20230929
20230929170213
ACCESSION NUMBER: 0001104659-23-105403
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230928
FILED AS OF DATE: 20230929
DATE AS OF CHANGE: 20230929
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lonial Sagar
CENTRAL INDEX KEY: 0001816609
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32639
FILM NUMBER: 231296503
MAIL ADDRESS:
STREET 1: C/O TG THERAPEUTICS, INC.
STREET 2: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TG THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001001316
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 363898269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: (212) 554-4484
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030310
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC
DATE OF NAME CHANGE: 20000330
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960703
4
1
tm2327273-5_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-09-28
0
0001001316
TG THERAPEUTICS, INC.
TGTX
0001816609
Lonial Sagar
3020 CARRINGTON MILL BLVD,
SUITE 475
MORRISVILLE
NC
27560
1
0
0
0
0
Common Stock
2023-09-28
4
A
0
20000
0
D
113878
D
Reflects a grant of restricted shares that will vest on June 14, 2024.
Includes shares of restricted Common Stock, which vest over various time periods.
/s/ Sagar Lonial
2023-09-29